Correlation Between Fulgent Genetics and US Physicalrapy

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fulgent Genetics and US Physicalrapy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fulgent Genetics and US Physicalrapy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fulgent Genetics and US Physicalrapy, you can compare the effects of market volatilities on Fulgent Genetics and US Physicalrapy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fulgent Genetics with a short position of US Physicalrapy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fulgent Genetics and US Physicalrapy.

Diversification Opportunities for Fulgent Genetics and US Physicalrapy

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Fulgent and USPH is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Fulgent Genetics and US Physicalrapy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US Physicalrapy and Fulgent Genetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fulgent Genetics are associated (or correlated) with US Physicalrapy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US Physicalrapy has no effect on the direction of Fulgent Genetics i.e., Fulgent Genetics and US Physicalrapy go up and down completely randomly.

Pair Corralation between Fulgent Genetics and US Physicalrapy

Given the investment horizon of 90 days Fulgent Genetics is expected to under-perform the US Physicalrapy. But the stock apears to be less risky and, when comparing its historical volatility, Fulgent Genetics is 1.05 times less risky than US Physicalrapy. The stock trades about -0.11 of its potential returns per unit of risk. The US Physicalrapy is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  8,220  in US Physicalrapy on August 31, 2024 and sell it today you would earn a total of  1,488  from holding US Physicalrapy or generate 18.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Fulgent Genetics  vs.  US Physicalrapy

 Performance 
       Timeline  
Fulgent Genetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fulgent Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
US Physicalrapy 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in US Physicalrapy are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, US Physicalrapy demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Fulgent Genetics and US Physicalrapy Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fulgent Genetics and US Physicalrapy

The main advantage of trading using opposite Fulgent Genetics and US Physicalrapy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fulgent Genetics position performs unexpectedly, US Physicalrapy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in US Physicalrapy will offset losses from the drop in US Physicalrapy's long position.
The idea behind Fulgent Genetics and US Physicalrapy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated